Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 1/20 | 0.67 |
| ▸ | AKR1B10 | O60218 | 1/20 | 0.67 |
| ▸ | CA1 | P00915 | 1/20 | 0.67 |
| ▸ | CA2 | P00918 | 1/20 | 0.67 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.67 |
| ▸ | CA7 | P43166 | 1/20 | 0.67 |
| ▸ | CA9 | Q16790 | 1/20 | 0.67 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.67 |
| ▸ | TAS1R3 | Q7RTX0 | 1/20 | 0.62 |
| ▸ | TAS1R1 | Q7RTX1 | 1/20 | 0.62 |
| ▸ | MAPT | P10636 | 4/20 | 0.58 |
| ▸ | NPC1 | O15118 | 3/20 | 0.58 |
| ▸ | RAB9A | P51151 | 3/20 | 0.58 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.58 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.58 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.58 |
| ▸ | HTT | P42858 | 1/20 | 0.58 |
| ▸ | MAOB | P27338 | 9/20 | 0.57 |
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.57 |
| ▸ | TP53 | P04637 | 2/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19244409 | 1.00 | CA12 (0.67) | CA12AKR1B10CA1CA2AKR1B1 | |
| SCHEMBL19244370 | 0.90 | CA12 (0.61) | CA12AKR1B10CA1CA2AKR1B1 | |
| SCHEMBL28155071 | 0.90 | CA12 (0.61) | CA12AKR1B10CA1CA2AKR1B1 | |
| SCHEMBL19244430 | 0.90 | CA12 (0.61) | CA12AKR1B10CA1CA2AKR1B1 | |
| SCHEMBL27472645 | 0.88 | TAS1R3 (0.59) | CA12AKR1B10CA1CA2AKR1B1 | |
| SCHEMBL19244201 | 0.88 | TAS1R3 (0.63) | CA12AKR1B10CA1CA2AKR1B1 | |
| SCHEMBL19244202 | 0.88 | TAS1R3 (0.63) | CA12AKR1B10CA1CA2AKR1B1 | |
| SCHEMBL14117363 | 0.85 | CA12 (0.60) | CA12AKR1B10CA1CA2AKR1B1 | |
| SCHEMBL342878 | 0.84 | CA12 (0.71) | CA12AKR1B10CA1CA2AKR1B1 | |
| SCHEMBL2775098 | 0.84 | MAOB (0.64) | CA12CA1CA2CA7CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 40 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025133665-A1 | OIL-IN-WATER EMULSION | L V M H RECHERCHE (FR) | 2025-06-26 | — | — | WO | disclosed |
| CN-114746064-B | Dual phase sunscreen composition | 莱雅公司 | 2025-05-06 | — | — | CN | disclosed |
| CN-114760974-B | Powdery cosmetic composition | 莱雅公司 | 2025-04-29 | — | — | CN | disclosed |
| EP-4452208-A1 | AQUEOUS EMULSION | L V M H RECHERCHE (FR) | 2024-10-30 | — | — | EP | disclosed |
| CN-118510486-A | Aqueous emulsion | LVMH研究公司 | 2024-08-16 | — | — | CN | disclosed |
| CN-117597102-A | Sun protection W/O emulsion | 莱雅公司 | 2024-02-23 | — | — | CN | disclosed |
| WO-2023118912-A1 | AQUEOUS EMULSION | L V M H RECHERCHE (FR) | 2023-06-29 | — | — | WO | disclosed |
| US-20230040911-A1 | Oil-In-Water-Type Emulsion Cosmetic | L V M H RECHERCHE (FR) | 2023-02-09 | — | — | US | disclosed |
| US-20230025603-A1 | SUN CARE COMPOSITION | L'OREAL (FR) | 2023-01-26 | — | — | US | disclosed |
| WO-2023277194-A1 | SUNSCREEN W/O EMULSION | L'OREAL (FR) | 2023-01-05 | — | — | WO | disclosed |
| US-20170242174-A1 | RESIN COMPOSITION AND OPTICAL COMPENSATION FILM USING SAME | TOSOH CORPORATION (JP) | 2017-08-24 | — | — | US | disclosed |
| EP-3208301-A1 | RESIN COMPOSITION AND OPTICAL COMPENSATION FILM USING SAME | Tosoh Corporation (JP) | 2017-08-23 | — | — | EP | disclosed |
| WO-2017110152-A1 | HIGH INTERNAL PHASE EMULSION COMPOSITION FOR IMPROVING ITS SPF AND RHEOLOGY | L'OREAL (FR) | 2017-06-29 | — | — | WO | disclosed |
| CN-106795327-A | Resin composition and optical compensation film using the same | 东曹株式会社 | 2017-05-31 | — | — | CN | disclosed |
| US-20150272897-A1 | COACERVATION ENCAPSULATION METHOD THAT DOES NOT INVOLVE THE USE OF TOXIC CROSS-LINKING AGENTS | SEPPIC SA (FR) | 2015-10-01 | — | — | US | disclosed |
| CN-104703686-A | Coacervation encapsulation method that does not involve use of toxic cross-linking agents | SEPPIC SA | 2015-06-10 | — | — | CN | disclosed |
| EP-2688650-A1 | FILM-FORMING COMPOSITION CONTAINING A SUN FILTER, AND USE THEREOF FOR THE TREATMENT OF SCARS | Laboratoires Urgo (FR) | 2014-01-29 | — | — | EP | disclosed |
| WO-2012131237-A1 | FILM-FORMING COMPOSITION CONTAINING A SUN FILTER, AND USE THEREOF FOR THE TREATMENT OF SCARS | LABORATOIRES URGO (FR) | 2012-10-04 | — | — | WO | disclosed |
| EP-2501359-A1 | A COSMETIC OR DERMATOLOGICAL COMPOSITION WITH LOW STICKINESS, CONTAINING A LIPOPHILIC ACTIVE INGREDIENT | L'Oréal (FR) | 2012-09-26 | — | — | EP | disclosed |
| WO-2011061864-A1 | A COSMETIC OR DERMATOLOGICAL COMPOSITION WITH LOW STICKINESS, CONTAINING A LIPOPHILIC ACTIVE INGREDIENT | L'OREAL (FR) | 2011-05-26 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230040911-A1 | Oil-In-Water-Type Emulsion Cosmetic | CUTA, PHOSPHO1, LIPE | CA12 1654/4885AKR1B10 3453/4885CA1 3906/4885 |
| US-20150272897-A1 | COACERVATION ENCAPSULATION METHOD THAT DOES NOT INVOLVE THE USE OF TOXIC CROSS-LINKING AGENTS | LIPA, MTCL3, LRAT | CA12 774/4885AKR1B10 2975/4885CA1 1838/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.